Unknown

Dataset Information

0

Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.

ABSTRACT:

SUBMITTER: Rodrigo C 

PROVIDER: S-EPMC8094590 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
| S-EPMC6657225 | biostudies-literature
Unknown Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.
| S-EPMC6657226 | biostudies-literature
Unknown Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria.
| S-EPMC7409770 | biostudies-literature
Unknown Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review.
| S-EPMC7071640 | biostudies-literature
Unknown Exposure-Response Analyses for Tafenoquine after Administration to Patients with Plasmodium vivax Malaria.
| S-EPMC4576039 | biostudies-literature
Unknown Plasmodium vivax Relapse Rates Following Plasmodium falciparum Malaria Reflect Previous Transmission Intensity.
| S-EPMC6548896 | biostudies-literature
Unknown Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data.
| S-EPMC6411314 | biostudies-literature
Unknown Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radical Cure of Plasmodium vivax Malaria and Prophylaxis of Malaria.
| S-EPMC6789594 | biostudies-literature
Unknown Geographical variation in Plasmodium vivax relapse.
| S-EPMC4021508 | biostudies-other
Unknown Variation in relapse frequency and the transmission potential of Plasmodium vivax malaria.
| S-EPMC4822465 | biostudies-literature